Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Retigabine> ?p ?o }
- Retigabine legalUk "POM".
- Retigabine legalUs "Schedule V".
- Retigabine licenceEu "Trobalt".
- Retigabine licenceUs "Ezogabine".
- Retigabine metabolism "Hepatic glucuronidation and acetylation. CYP not involved".
- Retigabine molecularWeight "303.331".
- Retigabine n "3".
- Retigabine o "2".
- Retigabine pregnancyUs "C".
- Retigabine proteinBound "60".
- Retigabine pubchem "121892".
- Retigabine routesOfAdministration "Oral".
- Retigabine smiles "O=CNc1cccNCc2ccccc2".
- Retigabine tradename "Trobalt, Potiga".
- Retigabine unii "12".
- Retigabine width "300".
- Retigabine wikiPageUsesTemplate Template:Anticonvulsants.
- Retigabine wikiPageUsesTemplate Template:Channelergics.
- Retigabine wikiPageUsesTemplate Template:Cite_journal.
- Retigabine wikiPageUsesTemplate Template:Drugbox.
- Retigabine wikiPageUsesTemplate Template:Drugs.com.
- Retigabine wikiPageUsesTemplate Template:Fdacite.
- Retigabine wikiPageUsesTemplate Template:GABAAR_PAMs.
- Retigabine wikiPageUsesTemplate Template:Reflist.
- Retigabine subject Category:Anticonvulsants.
- Retigabine subject Category:Carbamates.
- Retigabine subject Category:GABAA_receptor_positive_allosteric_modulators.
- Retigabine subject Category:Organofluorides.
- Retigabine subject Category:Potassium_channel_openers.
- Retigabine hypernym Anticonvulsant.
- Retigabine type ChemicalSubstance.
- Retigabine type Drug.
- Retigabine type Amide.
- Retigabine type Anticonvulsant.
- Retigabine type Carbamate.
- Retigabine type Drug.
- Retigabine type Ester.
- Retigabine type Organofluoride.
- Retigabine type Organohalide.
- Retigabine type Redirect.
- Retigabine type Organofluoride.
- Retigabine type Organohalide.
- Retigabine type ChemicalObject.
- Retigabine type Thing.
- Retigabine type Q8386.
- Retigabine comment "Retigabine (INN) or ezogabine (USAN), codenamed D-23129, is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients. The drug was developed by Valeant Pharmaceuticals and GlaxoSmithKline. It was approved by the European Medicines Agency under the trade name Trobalt on March 28, 2011, and by the United States Food and Drug Administration (FDA), under the trade name Potiga, on June 10, 2011.".
- Retigabine label "Retigabine".
- Retigabine sameAs Q2146170.
- Retigabine sameAs Retigabin.
- Retigabine sameAs Rétigabine.
- Retigabine sameAs Retigabina.
- Retigabine sameAs m.05q4_qf.
- Retigabine sameAs Retigabin.
- Retigabine sameAs Retigabin.
- Retigabine sameAs Q2146170.
- Retigabine wasDerivedFrom Retigabine?oldid=692171218.
- Retigabine depiction Retigabine2DCSD.svg.
- Retigabine isPrimaryTopicOf Retigabine.